The cluster shows moderate conviction from asset managers, but the lack of insider buying and the 45-day reporting lag reduce signal strength. Monitor next 10-Q for any operational catalyst (e.g., trial data or regulatory update) that could explain the accumulation.
SLS drugs
SLS drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 3 $8.87entry
- T+1 · 13d ago +3.04%α +1.39% · $9.14
- T+5 · 7d ago −5.64%α −5.05% · $8.37
- T+10 · todayOpen
- T+20 · in 15d Pending
- T+60 · in 3mo Pending
How similar events traded
Executive Summary
Five institutional investors increased their SLS holdings by a net $5.1M in Q3 2026, led by Creative Planning (doubled to $4.5M) and Kestra Advisory (doubled to $1.5M). One seller (Daiwa Securities) exited a $1.5M position. The cluster is entirely asset-manager driven with no insider buying, and the 13F data is 45+ days stale.
Key Financial Metrics
Institutional Positions
Net institutional flow: $5.1M
▲ Buyers (5)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Creative Planning | DOUBLED | +422% | $4.5M | $3.5M |
| Kestra Advisory Services | DOUBLED | +255.7% | $1.5M | $1.0M |
| Alps Advisors | ADD | +42.2% | $3.3M | $517.0K |
▼ Sellers (1)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Daiwa Securities Group | NEAR_EXIT | -99.9% | $1.5M | -$1.5M |
Key Facts
- 5 institutional buyers added a net $5.1M in Q3 2026
- Creative Planning doubled its position (+422% shares, now $4.5M)
- Kestra Advisory doubled its position (+256% shares, now $1.5M)
- Daiwa Securities exited 99.9% of its position (sold $1.5M)
- No open-market insider buying during the quarter (confluence score 32/100, institutions only)
- 13F data is as of Q3 2026 quarter-end, reported with a 45-day lag
Financial Impact
Net institutional buying of $5.1M, with total buyer holdings rising to $10.1M; one seller exited $1.5M
Risk Factors
- 13F data is stale (quarter-end, 45+ days old); positions may have been unwound
- No insider buying to corroborate the institutional thesis
- Single large seller (Daiwa) exited nearly fully, suggesting a divergent view
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-SLS-2026-Q3 |
Track record
16 reports on SLS
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 17, 2026today 424B5 Bearish 6/10 Entry $16.40 settles Feb 17
- Nov 17, 2026today Press Release Bearish 6/10 Entry $18.59 settles Feb 17
- Nov 17, 2026today 8-K Bullish 7/10 Entry $7.75 settles Feb 16
- Nov 17, 2026today Press Release Bullish 8/10 Entry $7.75 settles Feb 16
- Nov 12, 20265d ago 8-K Neutral 5/10 Entry $7.86 settles Feb 11
- Nov 10, 20267d ago SC 13G Neutral 3/10 Entry $8.37 settles Feb 8
- Nov 3, 202614d ago Institutional Cluster Neutral 3/10 Viewing Entry $8.87 settles Feb 1
- Oct 28, 202620d ago Press Release Mixed 7/10 Entry $10.38 settles Jan 26
- Oct 27, 202621d ago SC 13G/A Neutral 3/10 Entry $10.38 settles Jan 26
- Sep 25, 20267w ago Press Release Neutral 3/10 Entry $11.61 settles Dec 21
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers